Vij was moved to Rohtak after he complained of discomfort. He had received one shot of the two-dose COVID-19 vaccine ‘Covaxin’ but on 5 December tested positive for COVID-19
Ambala: Haryana Health Minister Anil Vij, who had tested positive for coronavirus recently, has been shifted to the PGIMS hospital at Rohtak from the civil hospital here after he complained of discomfort, doctors said on Sunday.
Doctors said the minister was shifted on Saturday night. Ambala’s civil surgeon Dr Kuldeep Singh said a team of doctors at the Rohtak hospital was monitoring his condition.
The 67-year-old BJP leader had offered to be the first volunteer in the phase three trials for Covaxin, an indigenous potential vaccine being developed by Bharat Biotech against COVID-19 .
He was administered the dose on 20 November at the Civil Hospital in Ambala Cantonment, about 50 kilometres from Chandigarh.
Bharat Biotech had said that clinical trials of the vaccine are based on a two-dose schedule, given 28 days apart. The vaccine efficacy will be determined two weeks after the second dose, it said.
COVAXIN has been designed to be protective two weeks after volunteers receive the 2nd dose.
The Union Health Ministry had also stepped in to say that Covaxin is a two-dose anti- Coronavirus vaccine and that Vij was given only the first dose a fortnight before he tested positive.
“The antibodies against the infection build up in a human being only after a specific number of days pass after the second dose of the vaccine is taken. This is a two-dose vaccine. The minister in question has taken only one dose of the vaccine,” the ministry had said in a statement..
Vij had earlier said he had gone to Panipat a few days ago where he spent 2-3 hours with a BJP leader, who too had tested positive for COVID-19 .
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
The Insidexpress is now on Telegram and Google News. Join us on Telegram and Google News, and stay updated.